mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
mRNA |
UNC1215 |
GDSC1000 |
pan-cancer |
AAC |
-0.003 |
0.9 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |